EU Health Commissioner Candidate Remains Question Mark For Pharma
This article was originally published in The Pink Sheet Daily
Executive Summary
The European Parliament has voted in favor of Maltese Foreign Minister Tonio Borg’s candidacy for the vacant EU health commissioner post despite his lack of health policy experience.
You may also be interested in...
EU Health Commissioner Dalli’s Resignation Leaves Unfinished Business For Pharma
John Dalli has resigned following allegations of fraud, bringing to an end a successful, but controversial career, and leaving the future of a number of legislative programs he championed – including anti-counterfeiting, risk assessments and biosimilar reviews – up in the air.
Rasi At The EMA: Redefining Benefit/Risk As Staggered Approvals Rise
The Executive Director of the European Medicines Agency Guido Rasi’s dual goals of increasing safety and overall accountability undoubtedly will benefit patients and industry alike, but a grueling task lies ahead.
MHRA’s Beneficial EU Relationship And Profitable Synergies With NICE: An Interview With Michael Rawlins
In December, Michael Rawlins was appointed head of the U.K.’s Medicines and Healthcare products Regulatory Agency. He recognizes the MHRA’s mutually beneficial relationship with European counterparts and is looking to safeguard synergies with other national regulatory bodies and NICE.